0SKN scored 70/100 for growth, blending a 3-year historical track record (60%) with analyst forward estimates (40%). Forward: analysts forecast 18.7% revenue growth next year. Overall, growth metrics are strong relative to this model's thresholds. Forecasts and analyst targets are estimates and may be inaccurate.

Insufficient price history to assess momentum. Score defaulted to neutral (50).

Insufficient profitability data available. Score defaulted to neutral (50).

Insufficient valuation data available. Score defaulted to neutral (50).

0SKN has a financial solvency risk score of 20/100. This shows lower leverage risk and a relatively healthy balance sheet. Current ratio of 1.49x confirms strong short-term liquidity. The company appears to have flexibility to invest, return capital, or absorb unexpected shocks.

0SKN scores 20/100 for operational quality, indicating low operational risk. The company shows highly stable margins (±2.0pp variance over 3 years). This combination of margins, cash generation, and capital efficiency indicates a comparatively resilient business model in this period. These metrics are model outputs and not personal investment advice.

0SKN has a volatility risk score of 50/100. This represents moderate-to-elevated volatility — above average but manageable. Investors may experience periodic double-digit declines in this profile.

0SKN has a market cap of £1.6B (Small Cap), resulting in a size risk score of 50/100. As a mid-cap company, it faces moderate size-related risk. Mid-caps are typically past the highest-risk startup phase but don't yet have the scale and diversification of large-caps. They can still face challenges from larger competitors and economic cycles, but have established operations and some market presence. Size risk is present but manageable with proper diversification.